Back to Search
Start Over
Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer.
- Source :
- Clinical Colorectal Cancer; Sep2018, Vol. 17 Issue 3, p206-214, 9p, 1 Diagram, 2 Charts, 2 Graphs
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 15330028
- Volume :
- 17
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical Colorectal Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 131428056
- Full Text :
- https://doi.org/10.1016/j.clcc.2018.03.008